# Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy

> **NCT02601170** · NA · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 22 (actual)

## Conditions studied

- Hemophilia
- Hemophilic Arthropathy

## Interventions

- **BIOLOGICAL:** Platelet-Rich Plasma Intra-Articular Injection
- **DRUG:** Hyaluronic Acid Viscosupplementation

## Key facts

- **NCT ID:** NCT02601170
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02601170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02601170, "Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02601170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*